The GLP-1 Generation: Are We Medicating Childhood Obesity Instead of Preventing It?
Prescriptions of GLP-1 drugs to children under 12 are rising at extraordinary speed. Are we turning a childhood health crisis into a lifetime pharmaceutical market? Listen to the audio version of this article: THE TOPLINE The GLP-1 boom is moving into the elementary-school years. A new Pediatrics study examined more than 3.5 million children ages […]









